Patent · US Active

IL-7 fusion proteins

US8338575B2 · kind B2 · utility

2Cited by
73References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 18, 2011
Grant dateDec 25, 2012
Priority date—
Expiry dateMay 18, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is directed to a fusion protein which includes a first portion including an immunoglobulin (Ig) chain and a second portion including interleukin-7 (IL-7).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.